Are you Dr. Polizzotto?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Bldg 10 Rm 6n110 # National Institutes of Health 9
Bethesda, MD 20892Phone+1 301-402-1541Fax+1 301-480-5955- Is this information wrong?
Clinical Trials
- Body Composition Sub-study of the D2EFT Trial Start of enrollment: 2019 Dec 05
- Inflammation and Co-Infections in D²EFT Start of enrollment: 2021 Feb 01
Publications & Presentations
PubMed
- 16 citationsSafety, activity, and long-term outcomes of pomalidomide in the treatment of Kaposi sarcoma among individuals with or without HIV infection.Ramya Ramaswami, Mark N. Polizzotto, Kathryn Lurain, Kathleen M. Wyvill, Anaida Widell, Jomy M. George, Priscila H. Goncalves, Seth M. Steinberg, Denise Whitby, Thomas...> ;Clinical Cancer Research. 2021 Dec 3
- 14 citationsTreatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate, , , , , , , , , , , , , , , > ;Blood. 2020 Nov 5
- 5 citationsDual infection and recombination of Kaposi sarcoma herpesvirus revealed by whole-genome sequence analysis of effusion samplesElena M. Cornejo Castro, Vickie Marshall, Justin B. Lack, Kathryn Lurain, Taina T. Immonen, Nazzarena Labo, Nicholas C Fisher, Ramya Ramaswami, Mark N. Polizzotto, Bra...> ;Virus Evolution. 2020 Jun 30
- Join now to see all
Press Mentions
- COVID Booster: Mixing and Matching Boosters, Delayed Surgery, and Testing Recalcitrant ChildrenJanuary 29th, 2022
- IV Hyperimmune Immunoglobulin No Help in Severe COVIDJanuary 28th, 2022
- International Trial Uncovers Crucial Gaps in Our Understanding of Influenza TherapiesNovember 27th, 2020
- Join now to see all